The Role of PTEN - HCV Core Interaction in Hepatitis C Virus Replication

Overview

Journal Sci Rep

Specialty Science

Date 2017 Jun 18

PMID 28623358

Citations 10

Authors

Qi Wu

Zhubing Li

Paul Mellor

Yan Zhou

Deborah H Anderson

Qiang Liu

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus (HCV) infection leads to severe liver diseases including hepatocellular carcinoma (HCC). Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a tumour suppressor, is frequently mutated or deleted in HCC tumors. PTEN has previously been demonstrated to inhibit HCV secretion. In this study, we determined the effects of PTEN on the other steps in HCV life cycle, including entry, translation, and replication. We showed that PTEN inhibits HCV entry through its lipid phosphatase activity. PTEN has no effect on HCV RNA translation. PTEN decreases HCV replication and the protein phosphatase activity of PTEN is essential for this function. PTEN interacts with the HCV core protein and requires R50 in domain I of HCV core and PTEN residues 1-185 for this interaction. This interaction is required for PTEN-mediated inhibition of HCV replication. This gives rise to a reduction in PTEN levels and intracellular lipid abundance, which may in turn regulate HCV replication. HCV core domain I protein increases the lipid phosphatase activity of PTEN in an in vitro assay, suggesting that HCV infection can also regulate PTEN. Taken together, our results demonstrated an important regulatory role of PTEN in the HCV life cycle.

Citing Articles

Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease.

Li Y, He H, Zhang N Curr Drug Targets. 2024; 25(3):171-189.

PMID: 38213163 DOI: 10.2174/0113894501278886231221092522.

Role of ROCK signaling in virus replication.

Kumar R, Barua S, Tripathi B, Kumar N Virus Res. 2023; 329:199105.

PMID: 36977446 PMC: 10194102. DOI: 10.1016/j.virusres.2023.199105.

Significance of native PLGA nanoparticles in the treatment of Alzheimer's disease pathology.

Anand B, Wu Q, Nakhaei-Nejad M, Karthivashan G, Dorosh L, Amidian S Bioact Mater. 2022; 17:506-525.

PMID: 36330076 PMC: 9614411. DOI: 10.1016/j.bioactmat.2022.05.030.

[Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis].

Glitscher M, Hildt E, Bender D Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022; 65(2):228-237.

PMID: 35015106 PMC: 8813796. DOI: 10.1007/s00103-021-03482-y.

Implications of exosomes derived from cholesterol-accumulated astrocytes in Alzheimer's disease pathology.

Wu Q, Cortez L, Kamali-Jamil R, Sim V, Wille H, Kar S Dis Model Mech. 2021; 14(10).

PMID: 34524402 PMC: 8560497. DOI: 10.1242/dmm.048929.

References

AlSaleh K, Delavalle P, Pillez A, Duverlie G, Descamps V, Rouille Y . Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J Virol. 2010; 84(24):12515-28. PMC: 3004332. DOI: 10.1128/JVI.01393-10. View

Zhang Y, Li R, Feng X, Zhang Y, Wang L . Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB. Int J Clin Exp Pathol. 2015; 7(11):7351-9. PMC: 4270593. View

Angus A, Loquet A, Stack S, Dalrymple D, Gatherer D, Penin F . Conserved glycine 33 residue in flexible domain I of hepatitis C virus core protein is critical for virus infectivity. J Virol. 2011; 86(2):679-90. PMC: 3255827. DOI: 10.1128/JVI.05452-11. View

Davidson L, Maccario H, Perera N, Yang X, Spinelli L, Tibarewal P . Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene. 2009; 29(5):687-97. PMC: 2816976. DOI: 10.1038/onc.2009.384. View

Song M, Salmena L, Pandolfi P . The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012; 13(5):283-96. DOI: 10.1038/nrm3330. View

Kwak J, Shim J, Tiwari I, Jang K . Hepatitis C virus core protein inhibits E6AP expression via DNA methylation to escape from ubiquitin-dependent proteasomal degradation. Cancer Lett. 2016; 380(1):59-68. DOI: 10.1016/j.canlet.2016.06.008. View

Leslie N, Batty I, Maccario H, Davidson L, Downes C . Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene. 2008; 27(41):5464-76. DOI: 10.1038/onc.2008.243. View

Chagpar R, Links P, Pastor M, Furber L, Hawrysh A, Chamberlain M . Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 2010; 107(12):5471-6. PMC: 2851819. DOI: 10.1073/pnas.0908899107. View

Hoffman B, Liu Q . Hepatitis C viral protein translation: mechanisms and implications in developing antivirals. Liver Int. 2011; 31(10):1449-67. DOI: 10.1111/j.1478-3231.2011.02543.x. View

10.

Messina J, Humphreys I, Flaxman A, Brown A, Cooke G, Pybus O . Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2014; 61(1):77-87. PMC: 4303918. DOI: 10.1002/hep.27259. View

11.

Wang Z, Wu N, Tesfaye A, Feinstone S, Kumar A . HCV infection-associated hepatocellular carcinoma in humanized mice. Infect Agent Cancer. 2015; 10:24. PMC: 4515941. DOI: 10.1186/s13027-015-0018-9. View

12.

Liu Z, Tian Y, Machida K, Lai M, Luo G, Foung S . Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry. J Biol Chem. 2012; 287(50):41922-30. PMC: 3516739. DOI: 10.1074/jbc.M112.414789. View

13.

Durmaz I, Bilget Guven E, Ersahin T, Ozturk M, Calis I, Cetin-Atalay R . Liver cancer cells are sensitive to Lanatoside C induced cell death independent of their PTEN status. Phytomedicine. 2016; 23(1):42-51. DOI: 10.1016/j.phymed.2015.11.012. View

14.

Jackel-Cram C, Qiao L, Xiang Z, Brownlie R, Zhou Y, Babiuk L . Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway. J Gen Virol. 2010; 91(Pt 6):1388-95. DOI: 10.1099/vir.0.017418-0. View

15.

Khan A, Miller M, Marcotrigiano J . HCV glycoprotein structures: what to expect from the unexpected. Curr Opin Virol. 2015; 12:53-8. PMC: 4505365. DOI: 10.1016/j.coviro.2015.02.004. View

16.

Shi Q, Hoffman B, Liu Q . PI3K-Akt signaling pathway upregulates hepatitis C virus RNA translation through the activation of SREBPs. Virology. 2016; 490:99-108. DOI: 10.1016/j.virol.2016.01.012. View

17.

Subramanyam D, Lamouille S, Judson R, Liu J, Bucay N, Derynck R . Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat Biotechnol. 2011; 29(5):443-8. PMC: 3685579. DOI: 10.1038/nbt.1862. View

18.

Scheel T, Rice C . Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med. 2013; 19(7):837-49. PMC: 3984536. DOI: 10.1038/nm.3248. View

19.

Wu Q, Liu Q . HBx truncation mutants differentially modulate SREBP-1a and -1c transcription and HBV replication. Virus Res. 2015; 210:46-53. DOI: 10.1016/j.virusres.2015.07.011. View

20.

Qiao L, Wu Q, Lu X, Zhou Y, Fernandez-Alvarez A, Ye L . SREBP-1a activation by HBx and the effect on hepatitis B virus enhancer II/core promoter. Biochem Biophys Res Commun. 2013; 432(4):643-9. DOI: 10.1016/j.bbrc.2013.02.030. View